Biotech Stocks See Major Selling Pressure
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/12/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- Former emir of Qatar, Sheikh Hamad bin Khalifa Al Thani, dies at 74
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Wall Street ends higher as investors turn to earnings season
UPDATE: BMO Capital Upgrades Biogen (BIIB) to Outperform
March 6, 2014 6:38 AM EST(Updated - March 6, 2014 12:10 PM EST)
BMO Capital upgraded Biogen (NASDAQ: BIIB) from Market Perform to Outperform with a price target of $422. Analyst Jim Birchenough, M.D. sees too many transformational opportunities to ignore.
The firm conducted an extensive pipeline review, and updated their financial model to reflect nearer-term opportunities for new product growth with ELOCTATE and... More
